Trium Capital LLP Akoya Biosciences, Inc. Transaction History
Trium Capital LLP
- $830 Million
- Q2 2025
A detailed history of Trium Capital LLP transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Trium Capital LLP holds 605,496 shares of AKYA stock, worth $781,089. This represents 0.09% of its overall portfolio holdings.
Number of Shares
605,496Holding current value
$781,089% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding AKYA
# of Institutions
57Shares Held
12MCall Options Held
40.4KPut Options Held
1K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$6.06 Million6.47% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$1.54 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX671KShares$865,5902.35% of portfolio
-
State Street Corp Boston, MA494KShares$636,9890.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...